Rating History for Rigel Pharmaceuticals (RIGL) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/3/2023 | Allison Bratzel | New Coverage | Neutral (N/A) |
2.00 (N/A) |
1.34 (1.08) |
-19.4% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/3/2023 | Allison Bratzel | New Coverage | Neutral (N/A) |
2.00 (N/A) |
1.34 (1.08) |
-19.4% | Details |
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
